Moderna extends lipids deal to boost COVID-19 vaccine output

Moderna said last week that the vaccine candidate, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers, offering a glimmer of hope for a vaccine among the most advanced in development.

from Moneycontrol Business News https://ift.tt/2XaaW31